Destroying tumor cells: Targeted immunotherapy using injectable materials
Researchers at the Terasaki Institute for Biomedical Innovation (TIBI) have developed and optimized a minimally invasive method for more targeted, efficient, and sustained delivery of immunotherapeutic treatments for cancer. ...
Aug 2, 2022
0
24